http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101336692-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F299-026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G49-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F222-402 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82B3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01G49-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F299-00 |
| filingDate | 2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101336692-B1 |
| titleOfInvention | Polyethylene oxide-based block copolymer having a hydrazide group and iron oxide nanoparticles stabilized thereby |
| abstract | The present invention is a polyethylene oxide block copolymer having a hydrazide group that can be used as a polymer material for drug delivery, having a pH response and anti-cancer efficacy, a method for preparing the same, an anticancer agent such as doxorubicin in the polyethylene oxide block copolymer, The present invention relates to iron oxide nanoparticles stabilized by a polymer drug in which folic acid and the like are bound, and the polyethylene oxide-based block copolymer which can be used for tumor cell imaging and hyperthermia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160001165-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160001175-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160066968-A |
| priorityDate | 2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.